A groundbreaking study conducted by AIG Hospitals has revealed that Endoscopic Sleeve Gastroplasty (ESG)—a minimally invasive, 45-minute procedure—offers significantly better short-term weight loss compared to standard oral anti-obesity medication.
The Food and Drug Administration (FDA) has granted fast-track approval to a new weight-loss pill developed by Eli Lilly, marking a major milestone in the treatment of obesity.
Tap to read more.......
